Woo et al., 2022 - Google Patents
Continuous centrifugal microfluidics (CCM) isolates heterogeneous circulating tumor cells via full automationWoo et al., 2022
View HTML- Document ID
- 8181751750991549495
- Author
- Woo H
- Kim S
- Kang H
- Lee S
- Lee S
- Kim J
- Gurel O
- Kim S
- Roh H
- Lee J
- Park Y
- Shin H
- Shin Y
- Lee S
- Oh S
- Kim Y
- Chae J
- Lee S
- Hong M
- Cho B
- Lee E
- Pantel K
- Kim H
- Kim M
- Publication year
- Publication venue
- Theranostics
External Links
Snippet
Understanding cancer heterogeneity is essential to finding diverse genetic mutations in metastatic cancers. Thus, it is critical to isolate all types of CTCs to identify accurate cancer information from patients. Moreover, full automation robustly capturing the full spectrum of …
- 208000005443 Circulating Neoplastic Cells 0 title description 141
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/04—Cell isolation or sorting
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Woo et al. | Continuous centrifugal microfluidics (CCM) isolates heterogeneous circulating tumor cells via full automation | |
| Rushton et al. | A review of circulating tumour cell enrichment technologies | |
| Yap et al. | Circulating tumor cells: a multifunctional biomarker | |
| Miller et al. | The Parsortix™ cell separation system—A versatile liquid biopsy platform | |
| Stoecklein et al. | Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution | |
| Kulasinghe et al. | The use of microfluidic technology for cancer applications and liquid biopsy | |
| Akpe et al. | Circulating tumour cells: a broad perspective | |
| Hvichia et al. | A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells | |
| Fachin et al. | Monolithic chip for high-throughput blood cell depletion to sort rare circulating tumor cells | |
| Labib et al. | Circulating tumor cell profiling for precision oncology | |
| Paoletti et al. | Circulating tumor cells | |
| Ozkumur et al. | Inertial focusing for tumor antigen–dependent and–independent sorting of rare circulating tumor cells | |
| Lemaire et al. | Fast and label-free isolation of circulating tumor cells from blood: from a research microfluidic platform to an automated fluidic instrument, VTX-1 liquid biopsy system | |
| Alunni-Fabbroni et al. | Circulating tumour cells in clinical practice: Methods of detection and possible characterization | |
| Magnusson et al. | Clinical-scale cell-surface-marker independent acoustic microfluidic enrichment of tumor cells from blood | |
| Au et al. | Clusters of circulating tumor cells: a biophysical and technological perspective | |
| Nanduri et al. | The prognostic role of circulating tumor cells in colorectal cancer | |
| Ren et al. | Entrapment of prostate cancer circulating tumor cells with a sequential size-based microfluidic chip | |
| Danova et al. | Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications | |
| Tadimety et al. | Liquid biopsy on chip: a paradigm shift towards the understanding of cancer metastasis | |
| Petrik et al. | Circulating tumor cells in colorectal cancer: detection systems and clinical utility | |
| MX2014006884A (en) | Apparatus, system and method for identifying circulating tumor cells. | |
| Agnoletto et al. | Heterogeneous circulating tumor cells in sarcoma: implication for clinical practice | |
| Hakim et al. | A new insight to deformability correlation of circulating tumor cells with metastatic behavior by application of a new deformability-based microfluidic chip | |
| Yadav et al. | Detection of circulating tumour cells in colorectal cancer: emerging techniques and clinical implications |